Management of hyperglycaemia in people with Type 1 diabetes on dialysis: What are the options? A case report and review of the literature

Abstract

Type 1 diabetes remains an important cause of end-stage kidney disease. In this report, we describe the use of automated insulin delivery technology to assist a person living with Type 1 diabetes to manage their glucose pre-, peri- and post-renal transplantation. In addition, we review the potential options available for managing such patients, including closed-loop technology, pancreatic and islet cell transplantation.